1. Home
  2. Bills
  3. S. 545

S. 545 · 119th Congress · 2025–2026

Combating Illicit Xylazine Act

S. 545 in the 119th Congress (2025–2026) was introduced on Feb 12, 2025, sponsored by Catherine Cortez Masto with 35 co-sponsors.

During the 119th Congress (2025–2026), Donald Trump was president, and Republicans held majorities in both the House and Senate.

Status
Introduced
Introduced
Feb 12, 2025
Co-sponsors
35
Policy area
Crime and Law Enforcement

What it does

Combating Illicit Xylazine Act This bill regulates xylazine under the Controlled Substances Act (CSA). Xylazine, also known as tranq , is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Catherine Cortez Masto (D-NV). Co-sponsors: 15 Democrats, 19 Republicans, 1 Independent.

Where it stands

  • IntroducedFeb 12, 2025
  • Passed the Senate—
  • Passed the House—
  • Sent to the President—
  • Became law—

Latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 372. (Apr 15, 2026)

More bills from Catherine Cortez Masto in the 119th Congress

Other Crime and Law Enforcement bills in the 119th Congress

Committees

  • Judiciary Committee

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “S. 545 (119th Congress): Combating Illicit Xylazine Act,” https://www.capitolreceipts.com/bill/119-s-545/combating-illicit-xylazine-act (accessed 2026-10-13).

Open the interactive version ›